Insilico Medicine Launches AI-Powered Virtual Aging Cell
Hong Kong, August 14, 2026 Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), has...
Drug Targets
Advertisement
Fannin Advances Ewing Sarcoma Therapy With New Grants
Houston, Texas, August 14, 2026 Fannin Partners, LLC has received new grants from the Congressionally Directed Medical Research Programs...
Insilico and THPharm Expand AI Drug Development Strategy
Seoul, South Korea, August 12, 2026 THPharm is advancing an artificial intelligence-driven indication expansion strategy in partnership with Insilico...
Ceribell Receives FDA Clearance for Advanced AI EEG Detection
Sunnyvale, Calif., August 10, 2026 Ceribell, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
Spyre Therapeutics Advances SPY772 into Phase 2 for Hidradenitis Suppurativa
Waltham, Mass., August 10, 2026 Spyre Therapeutics, Inc. announced the launch of its SPY772 combination program and initiation of...
Advertisements
Novo Nordisk and AWS Partner to Accelerate AI Drug Discovery
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
Advertisement
